ClinicalTrials.gg
Drug

Carotuximab clinical trials

Also written TRC105.

studies test it
25
open now
2
in phase 3
1
first study started
2007

How each study uses carotuximab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the carotuximab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

carotuximab
5
Carotuximab (TRC105)
3
Chimeric Antibody (TRC105) to CD105
3
Anti-Endoglin Chimeric Monoclonal Antibody TRC105
2

Development codes

TRC105
18
ENV105
1

Studies by the year they started

25 studies that test it; most in 2011 (6)

Studies that test carotuximab, by start year
YearStudies
20071
20101
20116
20124
20132
20154
20162
20173
20232

By phase

A phase 1/2 study counts in both.

Phase 1
14
Phase 2
18
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 11

Tracon Pharmaceuticals Inc. (13) · National Cancer Institute (NCI) (7) · University of Alabama at Birmingham (2) · Santen Inc. (1) · Edwin Posadas, MD (1) · Karen Reckamp, MD, MS (1)

Often tested with

Tested in the same studies.

Ranibizumab (1)

Studies

Open first, then newest update. How each study uses carotuximab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 25

See all 25 studies that test carotuximab →

Given beside what is tested · 1 — carotuximab is usual care or a partner of the new treatment

Codes

What other systems call carotuximab · ClinicalTrials.gg INT006257

  • MeSH (NLM) C579557carotuximabOne source NLM
  • UNII (FDA) YB2EWE6139CAROTUXIMABConfirmed FDA, NLM
  • NCI Thesaurus C74010CarotuximabOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.